EXOSYSTEMS’ exoRehab earns CES honours for remote rehabilitation technology
EXOSYSTEMS says its exoRehab platform, named a CES Innovation Awards 2026 Honoree, aims to make rehabilitation more measurable by combining wearable muscle sensing with remote clinical monitoring.
Recognition at CES 2026
EXOSYSTEMS’ exoRehab has been selected as a CES Innovation Awards 2026 Honoree in the Digital Health category and will be showcased at CES from 6 to 9 January. The recognition places the company among a growing group of health technology firms using sensors, software and data analytics to extend care beyond traditional clinical settings.
Turning rehab into measurable data
According to EXOSYSTEMS, exoRehab is designed as a Remote Therapeutic Monitoring solution that allows patients to complete rehabilitation exercises at home while remaining under clinical supervision. The system combines a lightweight, skin-friendly wearable with a mobile app for patients and a web-based dashboard for clinicians.
The wearable measures muscle activity using surface electromyography and tracks movement through an inertial measurement unit. Those signals are analysed using the company’s Muscle Function Index, a proprietary neuromuscular digital biomarker. EXOSYSTEMS says the index has been evaluated through a collaboration study with Roche Korea, adding clinical credibility to the underlying measurement approach.
Built for remote monitoring workflows
The company says exoRehab is designed to fit into Remote Therapeutic Monitoring workflows already used by clinics in the United States. It aligns with the relevant Current Procedural Terminology code set, allowing healthcare teams to track patient adherence and therapeutic activity while maintaining documentation required for reimbursement.
Rather than being sold directly to consumers, availability is through participating clinics and pilot programmes, reflecting the regulatory and reimbursement realities of digital health tools.
Live demonstrations in Las Vegas
Related reading
- Belkin heads to CES 2026 with Qi2 chargers, bigger power banks and a Switch 2 charging case
- Samsung to open CES 2026 with Sunday night showcase
EXOSYSTEMS will offer hands-on demonstrations at CES, showing the wearable applied directly to the skin, live muscle and movement signals within the app, and a guided home exercise flow. The demos will run at the Venetian Expo, Level 2, Global Pavilion, Hall A, Booth 50017.
Hooman Lee, chief executive of EXOSYSTEMS, said the goal was to make recovery visible as well as physical. He said objective muscle signals allow rehabilitation to be broken into trackable progress points that patients and clinicians can follow together.
The Recap
- exoRehab named CES Innovation Awards 2026 Honoree in Digital Health.
- Wearable measures muscle activity and movement using EMG and IMU.
- Hands-on demos scheduled at CES, 6–9 January, Booth 50017.
